How have HAVLF shares performed in 2023?

HAVN Life Sciences' stock was trading at $0.0595 at the beginning of 2023. Since then, HAVLF shares have decreased by 79.8% and is now trading at $0.0120. View the best growth stocks for 2023 here .

Are investors shorting HAVN Life Sciences?

HAVN Life Sciences saw a decrease in short interest in November. As of November 15th, there was short interest totaling 100 shares, a decrease of 99.6% from the October 31st total of 27,600 shares. Based on an average trading volume of 600 shares, the days-to-cover ratio is presently 0.2 days. View HAVN Life Sciences' Short Interest .

When is HAVN Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, January 15th 2024. View our HAVLF earnings forecast .

When did HAVN Life Sciences' stock split?

HAVN Life Sciences shares reverse split on the morning of Wednesday, August 3rd 2022. The 1-30 reverse split was announced on Wednesday, August 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of HAVN Life Sciences?

Shares of HAVLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

HAVN Life Sciences Stock Price, News & Analysis (OTCMKTS:HAVLF)

$0.01

-0.02 (-57.14%)

(As of 04:20 PM ET)

Compare

Today's Range: $0.01
▼
$0.02
50-Day Range: $0.01
▼
$0.03
52-Week Range: $0.00
▼
$0.10

Volume: 2,182 shs
Average Volume: 14,897 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Headlines Short Interest

About HAVN Life Sciences Stock (OTCMKTS:HAVLF)

HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.

HAVLF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HAVLF Stock News Headlines

November 10, 2023 | finance.yahoo.com

Canadian Investment Regulatory Organization Trading Halt - HAVN

October 2, 2023 | forbes.com

Discovering Life’s Story: Biology’s Beginnings By Joy Hakim— Review

November 29, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

September 4, 2023 | sports.yahoo.com

Life science founder to land £120m payout from private equity swoop

June 28, 2023 | finance.yahoo.com

HAVN.CN - HAVN Life Sciences Inc.

February 8, 2023 | investing.com

HAVN Life Sciences Inc (HAVN)

September 22, 2022 | yahoo.com

Heavy storms expected across Arizona through Thursday. Here's what to know

September 20, 2022 | finance.yahoo.com

HAVN Life Provides Corporate Update

November 29, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

September 14, 2022 | finance.yahoo.com

HAVN Life Sciences Inc. (HAVLF)

August 3, 2022 | finance.yahoo.com

IIROC Trading Halt - HAVN

August 3, 2022 | finance.yahoo.com

IIROC Trade Resumption - HAVN

August 1, 2022 | finanznachrichten.de

HAVN Life Sciences Inc.: HAVN Life Announces a 30:1 Consolidation of its Common Shares

July 29, 2022 | finance.yahoo.com

HAVN Life Announces a 30:1 Consolidation of its Common Shares

June 28, 2022 | seekingalpha.com

HAVN Life enters supply agreement with MPB Group

June 28, 2022 | benzinga.com

HAVN Life Enters Supply Agreement with MPB Group Inc.

June 22, 2022 | finance.yahoo.com

HAVN Life To Be Featured On Viewpoint with Dennis Quaid

June 14, 2022 | finance.yahoo.com

HAVN Life Announces Changes to the Board of Directors

June 6, 2022 | finance.yahoo.com

HAVN Life to Present at Upcoming LD Micro Invitational XII

May 16, 2022 | finance.yahoo.com

HAVN Life Announces Strategic Partnership with Non-Profit Coalition, TheraPsil

May 11, 2022 | finance.yahoo.com

HAVN Life Secures Supply Agreement with Atman Retreats

May 2, 2022 | finance.yahoo.com

HAVN Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia

April 30, 2022 | finance.yahoo.com

HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022

April 13, 2022 | financialpost.com

HAVN Life Launches the Brain Evolve Series

March 22, 2022 | seekingalpha.com

HAVN Life expands supply agreement with Mycotopia Therapies

March 22, 2022 | finance.yahoo.com

HAVN Life Expands Supply Agreement with Mycotopia Therapies Inc.

March 17, 2022 | finance.yahoo.com

Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc.

See More Headlines

Receive HAVLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HAVN Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 11/29/2023
Next Earnings (Estimated): 1/15/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:HAVLF
CUSIP: N/A
CIK: N/A
Web: www.havnlife.com
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Tim Moore (Age 64)
Interim CFO, CEO & Chairman
Comp: $126.05k
Ms. Jenna Pozar
Chief Operations Officer
Mr. Paul More
Controller

Key Competitors

View All Competitors

HAVLF Stock Analysis - Frequently Asked Questions

How have HAVLF shares performed in 2023?: HAVN Life Sciences' stock was trading at $0.0595 at the beginning of 2023. Since then, HAVLF shares have decreased by 79.8% and is now trading at $0.0120.
View the best growth stocks for 2023 here.
Are investors shorting HAVN Life Sciences?: HAVN Life Sciences saw a decrease in short interest in November. As of November 15th, there was short interest totaling 100 shares, a decrease of 99.6% from the October 31st total of 27,600 shares. Based on an average trading volume of 600 shares, the days-to-cover ratio is presently 0.2 days.
View HAVN Life Sciences' Short Interest.
When is HAVN Life Sciences' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, January 15th 2024.
View our HAVLF earnings forecast.

When did HAVN Life Sciences' stock split?: HAVN Life Sciences shares reverse split on the morning of Wednesday, August 3rd 2022. The 1-30 reverse split was announced on Wednesday, August 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.
How do I buy shares of HAVN Life Sciences?: Shares of HAVLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:HAVLF) was last updated on 11/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial